Renle Du

595 total citations
24 papers, 429 citations indexed

About

Renle Du is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Renle Du has authored 24 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Immunology. Recurrent topics in Renle Du's work include Cancer Cells and Metastasis (4 papers), Cancer-related gene regulation (4 papers) and Cancer Research and Treatments (3 papers). Renle Du is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Cancer-related gene regulation (4 papers) and Cancer Research and Treatments (3 papers). Renle Du collaborates with scholars based in China, United States and Singapore. Renle Du's co-authors include Wenzhi Shen, Rong Xiang, Na Luo, Wenjuan Gao, Xiaoyuan Zhang, Shuangtao Zhao, Na Li, Wancai Yang, Wei Zhou and Ruifang Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and British Journal of Cancer.

In The Last Decade

Renle Du

22 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renle Du China 13 231 140 109 107 53 24 429
Zike Yang China 6 219 0.9× 130 0.9× 114 1.0× 89 0.8× 46 0.9× 12 419
Xiaoyi Zhang China 12 161 0.7× 230 1.6× 90 0.8× 125 1.2× 66 1.2× 38 487
Yanping Zhong China 14 161 0.7× 172 1.2× 83 0.8× 72 0.7× 74 1.4× 37 476
Nick A. Kuburich United States 7 260 1.1× 134 1.0× 117 1.1× 51 0.5× 55 1.0× 14 443
Bettina Miller United States 10 230 1.0× 172 1.2× 115 1.1× 72 0.7× 34 0.6× 14 404
Zumin Xu China 13 294 1.3× 109 0.8× 141 1.3× 44 0.4× 47 0.9× 24 427
Masayo Umebayashi Japan 13 260 1.1× 261 1.9× 79 0.7× 187 1.7× 33 0.6× 37 530
Grace L. Wong United States 9 341 1.5× 229 1.6× 150 1.4× 82 0.8× 77 1.5× 13 578

Countries citing papers authored by Renle Du

Since Specialization
Citations

This map shows the geographic impact of Renle Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renle Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renle Du more than expected).

Fields of papers citing papers by Renle Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renle Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renle Du. The network helps show where Renle Du may publish in the future.

Co-authorship network of co-authors of Renle Du

This figure shows the co-authorship network connecting the top 25 collaborators of Renle Du. A scholar is included among the top collaborators of Renle Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renle Du. Renle Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Renle, et al.. (2026). SPP1 as a central mediator in the tumor microenvironment: Orchestrating cellular crosstalk, immune evasion, and therapy resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1881(2). 189555–189555.
2.
Wang, Keyan, Qing Li, Pengfei Ren, et al.. (2025). A nomogram based on autoantibodies for noninvasive detection of AFP-negative hepatocellular carcinoma: a multicenter study. British Journal of Cancer. 133(12). 1896–1906.
3.
Liao, Robert S., et al.. (2025). Plasma anti-PRTN3 IgG and IgM autoantibodies: novel biomarkers for early detection of lung adenocarcinoma. Frontiers in Immunology. 16. 1534078–1534078. 1 indexed citations
4.
Wang, Chen, Yutong Li, Linhong Wang, et al.. (2024). SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration. British Journal of Cancer. 130(11). 1770–1782. 29 indexed citations
5.
Wang, Shuying, Yifei Li, Xiaowen Yang, et al.. (2023). TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner. Cellular Oncology. 46(5). 1269–1283. 6 indexed citations
6.
Liu, Man, Renle Du, Xue Zhang, et al.. (2023). Novel BiomarkermiRNA-625-3pPromotes Cell Proliferation and Metastasis of Lung Adenocarcinoma by TargetingKLF9. Anticancer Research. 43(11). 4923–4935. 2 indexed citations
7.
Du, Renle, Chen Wang, Jingjing Liu, et al.. (2023). Phosphorylation of TGIF2 represents a therapeutic target that drives EMT and metastasis of lung adenocarcinoma. BMC Cancer. 23(1). 52–52. 7 indexed citations
8.
Zhang, Xue, Man Liu, Jiaqi Li, et al.. (2023). Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules. Journal of Proteome Research. 23(1). 277–288. 2 indexed citations
9.
Wang, Chen, et al.. (2022). Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma. BMC Cancer. 22(1). 932–932. 4 indexed citations
10.
Gao, Wenjuan, Xiaoli Dong, Renle Du, et al.. (2021). IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer. Theranostics. 11(6). 2564–2580. 64 indexed citations
11.
Zhang, Xiaoyuan, Renle Du, Na Luo, Rong Xiang, & Wenzhi Shen. (2020). Aspirin mediates histone methylation that inhibits inflammation-related stemness gene expression to diminish cancer stemness via COX-independent manner. Stem Cell Research & Therapy. 11(1). 370–370. 17 indexed citations
12.
Shen, Wenzhi, Xiaoyuan Zhang, Zhixin Zhang, et al.. (2020). CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis. Theranostics. 11(5). 2297–2317. 33 indexed citations
13.
Shen, Wenzhi, Xiaoyuan Zhang, Renle Du, et al.. (2020). Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner. British Journal of Cancer. 123(5). 730–741. 29 indexed citations
14.
Wang, Peng, Wenbo Wu, Ruifang Gao, et al.. (2019). Engineered Cell-Assisted Photoactive Nanoparticle Delivery for Image-Guided Synergistic Photodynamic/Photothermal Therapy of Cancer. ACS Applied Materials & Interfaces. 11(15). 13935–13944. 19 indexed citations
15.
Hao, Na, Wenzhi Shen, Renle Du, et al.. (2019). Phosphodiesterase 3A Represents a Therapeutic Target that Drives Stem Cell–like Property and Metastasis in Breast Cancer. Molecular Cancer Therapeutics. 19(3). 868–881. 22 indexed citations
16.
Du, Renle, Wenzhi Shen, Yi Liu, et al.. (2019). TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness. Signal Transduction and Targeted Therapy. 4(1). 60–60. 40 indexed citations
17.
Shen, Wenzhi, Xiaoyuan Zhang, Renle Du, et al.. (2018). ICAM3 mediates tumor metastasis via a LFA-1-ICAM3-ERM dependent manner. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(8). 2566–2578. 16 indexed citations
18.
Shen, Wenzhi, Shuangtao Zhao, Renle Du, et al.. (2018). ICAM3 mediates inflammatory signaling to promote cancer cell stemness. Cancer Letters. 422. 29–43. 32 indexed citations
19.
Zhang, Xiaoyuan, Renle Du, Wenjuan Gao, et al.. (2018). Low dosage of arsenic trioxide (As2O3) inhibits angiogenesis in epithelial ovarian cancer without cell apoptosis. JBIC Journal of Biological Inorganic Chemistry. 23(6). 939–947. 19 indexed citations
20.
Shen, Wenzhi, Renle Du, Jun Li, et al.. (2016). TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways. Signal Transduction and Targeted Therapy. 1(1). 16013–16013. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zike Yang Breakdown of academic impact, for papers by Xiaoyi Zhang Breakdown of academic impact, for papers by Yanping Zhong Breakdown of academic impact, for papers by Nick A. Kuburich Breakdown of academic impact, for papers by Bettina Miller Breakdown of academic impact, for papers by Zumin Xu Breakdown of academic impact, for papers by Masayo Umebayashi Breakdown of academic impact, for papers by Grace L. Wong
Rankless by CCL
2026